logo
logo
Sign in

Global Single Cell Genome Sequencing Market Growth Accelerated By High Adoption In Genetic And Cancer Research

avatar
Sneha
Global Single Cell Genome Sequencing Market Growth Accelerated By High Adoption In Genetic And Cancer Research

Single cell genome sequencing enables scientists to study genomic variations within and between cells, driving breakthroughs in disease research and therapeutic development. It allows monitoring changes within individual cells and understanding cellular heterogeneity, critical for studies in immunology, developmental biology and cancer.

The global single cell genome sequencing market is estimated to be valued at US$ 2.28 Bn in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Adoption of single cell genome sequencing techniques is growing rapidly in the fields of genetic and cancer research. Scientists are leveraging the power of single cell analyses to better understand cancer initiation and progression at the single cell level. Recent innovations like droplet-based platforms have made single cell genomic analyses faster, easier and more accessible to researchers. As single cell genome sequencing helps unravel complex disease mechanisms and identify new therapeutic targets, its adoption is expected to accelerate in the coming years, driving robust growth of the global market.

Segment Analysis

The single cell genome sequencing market dominates by tissue/cell sorting segmentation. This is because tissue/cell sorting technique provide isolation of viable live cells according to their physical and chemical properties. This further enable analysis of individual cell which advance the discovery of disease biology and cell type identification.

Key Takeaways

The Global Single Cell Genome Sequencing Market Size is expected to witness high growth. The global single cell genome sequencing market is estimated to be valued at US$ 2.28 Bn in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023 to 2030.

Regional analysis shows that North America region holds largest market share and is expected to dominates the market during the forecast period. This is attributed to increasing R&D expenditures by pharmaceutical and biotechnology companies and growing adoption of single cell analysis in cancer research and immunology in the region.

Key players operating in the single cell genome sequencing market are Logitech International SA, Microsoft Corporation, Datadesk Technologies, Inc., Fentek Industries Inc., Adesso AG, Shenzhen V4 Electronic Co., Ltd., Fellowes Limited, Kinesis Corporation, Gold Touch Enterprise Inc., and Posturite UK Ltd.

Explore more information on this topic, Please visit -

https://www.insightprobing.com/single-cell-genome-sequencing-market-size-and-trends-analysis/

Explore more trending article related this topic -

https://www.newsintv.com/health/cell-and-gene-therapy-revolutionizing-medical-science/

collect
0
avatar
Sneha
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more